Harfst & Associates’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.64M Buy
14,025
+26
+0.2% +$5.52K 0.4% 43
2026
Q2
$2.93M Buy
13,999
+73
+0.5% +$14.5K 0.45% 38
2026
Q1
$2.29M Buy
13,926
+1,013
+8% +$175K 0.41% 41
2025
Q4
$2.29M Sell
12,913
-239
-2% -$39.9K 0.41% 39
2025
Q3
$2.09M Buy
13,152
+99
+0.8% +$14.6K 0.39% 44
2025
Q2
$1.84M Buy
13,053
+7,417
+132% +$911K 0.38% 46
2025
Q1
$658K Buy
+5,636
New +$726K 0.15% 79

Other funds holding MS

Harfst & Associates's MS Position: Q3 2026 in Review

Harfst & Associates increased its Morgan Stanley (MS) stake by 0.19% in Q3 2026, buying an estimated $5.52K and bringing the position to 14,025 shares worth $2.64M. The position accounts for 0.4% of the portfolio, ranked #43.

Harfst & Associates first reported a position in MS in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.93M in Q2 2026. 571 funds tracked by Wall St. Rank hold MS as of Q3 2026.

  • Harfst & Associates held 14,025 shares of Morgan Stanley worth $2.64M as of Q3 2026.
  • Harfst & Associates bought 26 Morgan Stanley shares in Q3 2026, an estimated $5.52K.
  • Morgan Stanley made up 0.4% of Harfst & Associates's portfolio in Q3 2026, its #43 holding.
  • Harfst & Associates first reported a position in Morgan Stanley in Q1 2025 and has held it in 7 quarters since.
  • Harfst & Associates's Morgan Stanley position peaked at $2.93M in Q2 2026.
  • 571 funds tracked by Wall St. Rank held Morgan Stanley as of Q3 2026.

Based on Harfst & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.